Description Usage Format References
We demonstrate the application of the CMEA package by using the transcriptomic and single cell morphological profiles of human bone osteosarcoma cells (U-2 OS cells) in response to the 9515 drugs or small molecule compounds (1). The raw data include the transcripotimic profiles of 20340 drugs and small compound moleculess, and processed version of this data is available as supplementary of (2). The intersection of transcriptomic and single-cell morphological profiles includes 9515 drugs and small compound molecules, and use as a backend repository of CMEA package. The transcriptomic profile in backend repository is 9515*978 matric, including the fold change of the 978 landmark gene expression in response to the treatment of U-2 OS cells with 9515 drugs and small compound molecules. We use subset of complete data set as an example (162 profles), and complete data are available at (https://bitbucket.org/isarnassiri/cmeadata).
1 |
An object of class data.frame
with 162 rows and 978 columns.
1. Wawer, M.J., Jaramillo, D.E., Dancik, V., Fass, D.M., Haggarty, S.J., Shamji, A.F., Wagner, B.K., Schreiber, S.L. and Clemons, P.A. (2014) Automated Structure-Activity Relationship Mining: Connecting Chemical Structure to Biological Profiles. Journal of Biomolecular Screening, 19,738-748. 2. Wang, Z., Clark, N.R. and Ma'ayan, A. (2016) Drug-induced adverse events prediction with the LINCS L1000 data. Bioinformatics, 32, 2338-2345.
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.